We found in this study that the most common (about 1%) AD-associated ACE mutation, Y215C [6], is truly damaging and likely transport-deficient, because most of the carriers of these mutations possessed only about half as much ACE in the blood as control subjects without ACE mutations. The gene discussed is ACE; the disease is Alzheimer disease.